In a recent transaction, James H. Thrall, a director at Lantheus (NASDAQ:LNTH) Holdings, Inc. (NASDAQ:LNTH), sold 1,000 shares of the company's common stock. The shares were sold at a price of $94 ...

A challenging economic environment is constricting biotech deal flow. But for well-capitalized Lantheus, these tough times present an opportunity to build out its R&D pipeline. Buoyed by a new ...

Shares of radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) jumped 19.8% in the morning session after the company delivered strong fourth-quarter 2024 results, with revenue and earnings ...

BEDFORD, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to ...

Raymond James Financial Inc. acquired a new stake in Lantheus in the fourth quarter worth $36,183,000. Groupama Asset Managment bought a new position in shares of Lantheus during the third quarter ...

Investors considering a purchase of Lantheus Holdings Inc (Symbol: LNTH) stock, but tentative about paying the going market price of $102.17/share, might benefit from considering selling puts ...